Related Experiment Video
Updated: Oct 7, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Evaluating the effectiveness of evidence-based guidelines for the use of spacer devices in children with acute asthma
M Gazarian1, R L Henry, S R Wales
1School of Women's and Children's Health, Sydney Children's Hospital, NSW.
Insights
This study successfully transitioned pediatric asthma treatment from nebulizers to metered dose inhalers with spacers, demonstrating no change in hospitalization rates or duration. This shift in acute asthma care improved bronchodilator delivery in children.
Area of Science:
- Pediatric Emergency Medicine
- Respiratory Medicine
- Clinical Practice Change
Background:
- Acute asthma exacerbations in children often require bronchodilator therapy.
- Nebulizers have been the traditional delivery method, but metered dose inhalers with spacers offer potential advantages.
Purpose of the Study:
- To evaluate the implementation of a practice change from nebulizers to metered dose inhalers and holding chambers (spacers) for children with mild to moderate acute asthma.
- To assess the impact of this change on clinical outcomes, including hospitalization and length of stay.
Main Methods:
- A before-and-after study comparing children with acute asthma presenting to a tertiary care children's hospital emergency department.
- Intervention involved developing evidence-based guidelines for spacer use and implementing a multifaceted guideline program.
- Data collected on physician prescribing practices and clinical outcomes (hospitalization, ICU admission, length of stay).
Main Results:
- The proportion of children treated with spacers in the emergency department increased from 0% in 1997 to 94% in 1999.
- Hospital admission rates remained similar between the two periods (29% vs. 30%).
- The median length of stay for children with asthma was comparable in both study years (1.7 days).
Conclusions:
- Standard practice for bronchodilator delivery in mild to moderate acute asthma in children was successfully shifted from nebulizers to spacers.
- This change in practice was achieved without adversely affecting the need for hospitalization or its duration.
Objective:
To change standard practice from using nebulisers to metered dose inhalers and holding chambers (spacers) in children presenting with mild to moderate acute asthma.
Design:
A before-after comparison of children with acute asthma presenting to the emergency department (ED) between August and October 1999 with those presenting between June and August 1997.
Setting:
A tertiary care metropolitan children's hospital.
Interventions:
Evidence-based clinical practice guidelines for using spacers were developed by a local multidisciplinary consensus process. A multifaceted guideline implementation program was used in 1999.
Main Outcome Measures:
Physician prescribing practices (spacer use); clinical outcomes (need for hospitalisation, admission to intensive care unit, and length of stay [LOS]).
Results:
75 of 247 children (30%; 95% CI, 25%-36%) required hospital admission in 1999. This was similar to the 1997 study period, when 95 of 326 (29%; 95% CI, 24%-34%) children were admitted. Of those with mild to moderate asthma, 160 (68%) received bronchodilators in the ED; 151 (94%) were initially treated with a spacer device in 1999. In 1997, no children were initially treated with spacers in the ED. The median (range) LOS in hospital for children with asthma of all severities was 1.7 (0.5-19.8) days in 1999 and 1.7 (0.2-7.6) days in 1997 (P=0.85).
Conclusions:
We successfully changed standard practice from using nebulisers to spacers for bronchodilator delivery in children with mild to moderate acute asthma, with no difference in the need for or duration of hospitalisation.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Inhaled Medications
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Nursing Management
First, in...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...